Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings.

ABSTRACT:

Importance

As US health care systems shift to human papillomavirus (HPV)-based cervical cancer screening, more patients are receiving positive high-risk non-16/18 genotype HPV results and negative for intraepithelial lesion or malignancy (NILM) cytological findings. Risk-based management guidelines recommend 2 consecutive negative annual results to return to routine screening.

Objective

To quantify patterns of surveillance testing and associated outcomes for patients after an HPV-positive results and NILM cytologic findings.

Design, setting, and participants

This cohort study analyzed patients in the METRICS (Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings and Populations) cohort of the PROSPR II (Population-Based Research to Opti

SUBMITTER: Tiro JA 

PROVIDER: S-EPMC11742536 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature